Trial Profile
A Retrospective study to evaluate the safety, efficacy and the main reasons for the Raltegravir prescription in pre-treated HIV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2017 New trial record
- 05 Jun 2017 Results presented at the ASM Microbe 2017